M D Meyer Selected Research

Prostatic Hyperplasia (Benign Prostatic Hyperplasia)

6/2001	Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.
4/2000	Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M D Meyer Research Topics

Disease

8	Pain (Aches) 05/2015 - 03/2000
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 06/2001 - 04/2000
1	Hyperalgesia 05/2015
1	Postoperative Pain 06/2009
1	Neuralgia (Stump Neuralgia) 06/2009
1	Alzheimer Disease (Alzheimer's Disease) 03/2008
1	Schizophrenia (Dementia Praecox) 03/2008
1	Developmental Dysplasia of the Hip 08/2004
1	Hip Dislocation 08/2004
1	Acute Pain 07/2000

Drug/Important Bio-Agent (IBA)

5	Analgesics (Analgesic Drugs)IBA 06/2009 - 03/2000
3	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2015 - 04/2000
3	CannabinoidsIBA 06/2009 - 01/2008
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2001 - 03/2000
2	CB2 Cannabinoid ReceptorIBA 01/2008 - 09/2006
2	Nicotine FDA Link 10/2001 - 03/2000
2	IsoindolesIBA 06/2001 - 04/2000
2	A 85380IBA 07/2000 - 07/2000
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 05/2015
1	A-1262543IBA 05/2015
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 06/2009
1	Cannabinoid Receptor AgonistsIBA 06/2009
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 03/2008
1	(1- (2- morpholin- 4- yl- ethyl)- 1H- indol- 3- yl)- (2,2,3,3- tetramethylcyclopropyl)methanoneIBA 01/2008
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2008
1	Dictyostelium severin protein (severin)IBA 08/2004
1	Antisense OligonucleotidesIBA 07/2000
1	Ether (Diethyl Ether)IBA 03/2000
1	5-(2-azetidinylmethoxy)-2-chloropyridineIBA 03/2000
1	epibatidineIBA 03/2000

Therapy/Procedure

1	Ligation 05/2015
1	Aftercare (After-Treatment) 08/2004
1	Injections 07/2000